| |
| |
|
| Insider
Information: |
Andrews Ronald Asbury |
| Relationship: |
Director |
| City: |
San Juan Capistrano |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
592,830 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$118,204 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
592,830 |
|
|
| Total
Value |
$118,204 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -17.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clarient Inc |
CLRT |
Vice-Chairman and CEO,... |
2010-12-22 |
0 |
2004-08-06 |
0 |
Premium* |
|
|
Cardiac Science Corp |
CSCX |
Director |
2010-12-01 |
0 |
2010-11-05 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Former CEO, Director |
2022-12-01 |
583,212 |
2018-07-26 |
0 |
Premium* |
|
|
Oxford Immunotec Global Plc |
OXFD |
|
2021-03-08 |
0 |
2020-06-24 |
0 |
Premium* |
|
|
Precipio Inc |
PRPO |
Director |
2024-07-15 |
9,618 |
2023-09-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRPO |
Precipio Inc |
Director |
– • – |
2024-07-15 |
4 |
A |
$4.63 |
$9,987 |
D/D |
2,157 |
9,618 |
0 |
- |
|
| PRPO |
Precipio Inc |
Director |
– • – |
2024-04-15 |
4 |
A |
$6.66 |
$20,999 |
D/D |
3,153 |
7,461 |
0 |
- |
|
| PRPO |
Precipio Inc |
Director |
– • – |
2023-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,005 |
4,308 |
0 |
- |
|
| PRPO |
Precipio Inc |
Director |
– • – |
2023-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,060 |
6,060 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Former CEO |
• • – |
2022-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
250,000 |
583,212 |
0 |
- |
|
| OCX |
Oncocyte Corp |
President & CEO |
• • – |
2022-08-16 |
4 |
B |
$0.96 |
$38,400 |
D/D |
40,000 |
333,212 |
2.81 |
% |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2022-03-16 |
4 |
B |
$1.28 |
$64,150 |
D/D |
50,000 |
293,212 |
2.81 |
- |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,000 |
259,046 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2021-07-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,834) |
243,212 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2021-06-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,873) |
194,046 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2021-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
106,221 |
219,919 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2021-03-19 |
4 |
B |
$4.79 |
$52,702 |
D/D |
11,000 |
113,698 |
2.81 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
|
• • – |
2021-03-08 |
4 |
D |
$22.00 |
$89,782 |
D/D |
(4,081) |
0 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Chief Executive Officer |
• • – |
2020-08-03 |
4 |
B |
$1.35 |
$53,880 |
D/D |
40,000 |
102,698 |
2.81 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
Director |
• • – |
2020-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,081 |
4,081 |
0 |
- |
|
| OCX |
Oncocyte Corp |
CEO and President |
• • – |
2020-03-31 |
4 |
B |
$2,372.00 |
$42,696,000 |
D/D |
18,000 |
62,698 |
2.81 |
- |
|
| OCX |
Oncocyte Corp |
CEO and President |
• • – |
2020-03-30 |
4 |
B |
$2.26 |
$61,454 |
D/D |
27,216 |
44,698 |
2.81 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2018-07-26 |
4 |
B |
$0.00 |
$0 |
D/D |
17,482 |
17,482 |
2.31 |
- |
|
| CLRT |
Clarient Inc |
Vice-Chairman and CEO |
• • – |
2010-12-22 |
4 |
D |
$5.00 |
$2,500,000 |
D/D |
(500,000) |
0 |
0 |
- |
|
| CLRT |
Clarient Inc |
Vice-Chairman and CEO |
• • – |
2010-12-17 |
4 |
D |
$5.00 |
$362,500 |
D/D |
(72,500) |
500,000 |
0 |
- |
|
| CSCX |
Cardiac Science Corp |
Director |
– • – |
2010-12-01 |
4 |
D |
$2.30 |
$2,300 |
D/D |
(1,000) |
0 |
0 |
- |
|
| CSCX |
Cardiac Science Corp |
Director |
– • – |
2010-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| CLRT |
Clarient Inc |
Vice-Chairman and CEO |
• • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
572,500 |
0 |
- |
|
| CLRT |
Clarient Inc |
Vice-Chairman and CEO |
• • – |
2010-03-12 |
4 |
B |
$2.41 |
$28,920 |
D/D |
12,000 |
72,500 |
2.81 |
- |
|
| CLRT |
Clarient Inc |
President and CEO |
• • – |
2008-09-18 |
4 |
B |
$1.93 |
$14,510 |
D/D |
7,500 |
60,500 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
